246 related articles for article (PubMed ID: 28081671)
1. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
Mohammed I; Iliyasu G; Habib AG
Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
[TBL] [Abstract][Full Text] [Related]
2. Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.
Novak RT; Ronveaux O; Bita AF; Aké HF; Lessa FC; Wang X; Bwaka AM; Fox LM
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S279-S285. PubMed ID: 31671452
[TBL] [Abstract][Full Text] [Related]
3. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
[TBL] [Abstract][Full Text] [Related]
4. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
Xie O; Pollard AJ; Mueller JE; Norheim G
Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
[TBL] [Abstract][Full Text] [Related]
5. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.
Trotter CL; Cibrelus L; Fernandez K; Lingani C; Ronveaux O; Stuart JM
Vaccine; 2015 Nov; 33(46):6212-7. PubMed ID: 26463444
[TBL] [Abstract][Full Text] [Related]
6. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
[TBL] [Abstract][Full Text] [Related]
7. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine].
Nicolas P
Med Sante Trop; 2012; 22(3):246-58. PubMed ID: 23186941
[TBL] [Abstract][Full Text] [Related]
8. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
Daugla DM; Gami JP; Gamougam K; Naibei N; Mbainadji L; Narbé M; Toralta J; Kodbesse B; Ngadoua C; Coldiron ME; Fermon F; Page AL; Djingarey MH; Hugonnet S; Harrison OB; Rebbetts LS; Tekletsion Y; Watkins ER; Hill D; Caugant DA; Chandramohan D; Hassan-King M; Manigart O; Nascimento M; Woukeu A; Trotter C; Stuart JM; Maiden M; Greenwood BM
Lancet; 2014 Jan; 383(9911):40-47. PubMed ID: 24035220
[TBL] [Abstract][Full Text] [Related]
9. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
Novak RT; Kambou JL; Diomandé FV; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Lingani C; Martin SW; Hatcher C; Mayer LW; Laforce FM; Avokey F; Djingarey MH; Messonnier NE; Tiendrébéogo SR; Clark TA
Lancet Infect Dis; 2012 Oct; 12(10):757-64. PubMed ID: 22818241
[TBL] [Abstract][Full Text] [Related]
10. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.
Mustapha MM; Harrison LH
Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624
[TBL] [Abstract][Full Text] [Related]
11. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.
MenAfriCar consortium
J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956
[TBL] [Abstract][Full Text] [Related]
12. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.
Collard JM; Issaka B; Zaneidou M; Hugonnet S; Nicolas P; Taha MK; Greenwood B; Jusot JF
BMC Infect Dis; 2013 Dec; 13():576. PubMed ID: 24313998
[TBL] [Abstract][Full Text] [Related]
14. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.
Sidikou F; Zaneidou M; Alkassoum I; Schwartz S; Issaka B; Obama R; Lingani C; Tate A; Ake F; Sakande S; Ousmane S; Zanguina J; Seidou I; Nzeyimana I; Mounkoro D; Abodji O; Wang X; Taha MK; Moulia-Pelat JP; Pana A; Kadade G; Ronveaux O; Novak R; Oukem-Boyer OOM; Meyer S;
Lancet Infect Dis; 2016 Nov; 16(11):1288-1294. PubMed ID: 27567107
[TBL] [Abstract][Full Text] [Related]
15. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
Mueller JE; Borrow R; Gessner BD
Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
[TBL] [Abstract][Full Text] [Related]
16. Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
; Altmann D; Aseffa A; Bash M; Basta N; Borrow R; Broome C; Caugant D; Clark T; Collard JM; Djingarey M; Goldblatt D; Greenwood B; Griffiths U; Hajjeh R; Hassan-King M; Hugonnet S; Kimball AM; LaForce M; MacLennan C; Maiden MC; Manigart O; Mayer L; Messonnier N; Moisi J; Moore K; Moto DD; Mueller J; Nascimento M; Obaro S; Ouedraogo R; Page AL; Perea W; Pluschke G; Preziosi MP; Sow S; Stephens D; Stuart J; Thomson M; Tiendrebeogo S; Trape JF; Vernet G
Vaccine; 2013 Mar; 31(11):1453-7. PubMed ID: 23273967
[TBL] [Abstract][Full Text] [Related]
17. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
[TBL] [Abstract][Full Text] [Related]
19. Control of meningococcal meningitis outbreaks in sub-Saharan Africa.
Chippaux JP
J Infect Dev Ctries; 2008 Oct; 2(5):335-45. PubMed ID: 19745499
[TBL] [Abstract][Full Text] [Related]
20. Serogroup A meningococcal conjugate vaccines in Africa.
Kristiansen PA; Jørgensen HJ; Caugant DA
Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]